PUBLICATIONS

Refereed Articles.

1. Cook DR, Brandom BW, Shiu G, Wolfson B: The inspired median effective dose, brain concentration of anesthesia, and cardiovascular index for halothane in young rats. Anesth Analg 60:182-185, 1981.

2. Cook DR, Brandom BW: Enflurane, halothane, and isoflurane inhibit removal of 5-hydroxytryptamine from pulmonary circulation. Anesth Analg 61:671-675, 1982.

3. Brandom BW, Brandom RB, Cook DR: Uptake and distribution of halothane in infants and adults in vivo measurements and computer simulations. Anesth Analg 62:404-410, 1983.

4. Brandom BW, Rudd GD, Cook DR: Clinical pharmacology of atracurium in pediatric patients. Brit J Anaesth 55:117S-121S, 1983.

5. Brandom BW, Woelfel SK, Cook DR: Clinical pharmacology of atracurium in infants. Anesth Analg 63:309-312, 1984.

6. Alifimoff JK, Kaul S, Brandom BW, Cook DR: Enflurane, halothane and isoflurane do not inhibit angiotensin converting enzyme activity. Can Anesth Soc J 32:351-357, 1985.

7. Stiller RL, Brandom BW, Cook DR: Determination of atracurium in plasma by high-performance liquid chromatography. Anesth Analg 64:58-62, 1985.

8. Brandom BW, Cook DR, Woelfel SK, Rudd GD: Atracurium infusion requirements in children during halothane, isoflurane, and narcotic anesthesia. Anesth Analg 64:471-476, 1985.

9. Pollock BG, Perel JM, Brandom BW, Antelman S, Kupfer DJ: Understanding the response lag to tricyclics I. Application of pulse-loading regimens with intravenous clomipramine. Psychopharmacology 22:214-219, 1986.

10. Brandom BW, Stiller RL, Cook DR, Woelfel SK, Chakravorti S, Lai A: Pharmacokinetics of atracurium in anesthetized infants and children. Br J Anesth 58:1210-1213, 1986.

11. Sarner JB, Brandom BW, Cook DR, Dong ML, Horn MC, Woelfel SK, Davis PJ, Rudd GD, Foster VJ, McNulty BF: Clinical pharmacology of doxacurium chloride (BW A938U) in children. Anesth Analg 67:303-306, 1988.

12. Davis PJ, Stiller RL, Cook DR, Brandom BW, Davin-Robinson KA: Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure. Anesth Analg 67:268-271, 1988.

13. Weber S, Brandom BW, Powers DM, Sarner JB, Woelfel SK, Cook DR, Foster VJ, McNulty BF, Weakly JN: Mivacurium chloride (BW B1090U) induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients. Anesth Analg 67:495-499, 1988.

14. Sarner JB, Brandom BW, Woelfel SK, Dong ML, Horn MC, Cook DR, McNulty BF, Foster VJ: Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia. Anesth Analg 68:116-121, 1989.

15. Davis PJ, Stiller RL, Cook DR, Brandom BW, Davis JE, Scierka AM: Effects of cholestatic hepatic disease and chronic renal failure on alfentanil pharmacokinetics in children. Anesth Analg 68:579-583, 1989.

16. Cook DR, Stiller RL, Weakly JN, Chakravorti S, Brandom BW, Welch RM: In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine. Anesth Analg 68:452-456, 1989.

17. Brandom BW, Woelfel SK, Cook DR, Weber S, Powers DM, Sarner JB, Weakly JN: Comparison of mivacurium chloride (BW B1090U) and suxamethonium chloride administered by bolus and infusion during nitrous oxide-oxygen-opioid anesthesia. Br J Anaesth 62:488-493, 1989.

18. Law SC, Ramzan IM, Brandom BW, Cook DR: Intravenous ranitidine antagonizes intense atracurium-induced neuromuscular blockade in rats. Anesth Analg 69:611-613, 1989.

19. Tullock WC, Diana P, Cook DR, Wilks DH, Brandom BW, Stiller RL, Beach CA: Neuromuscular and cardiovascular effects of high-dose vecuronium. Anesth Analg 70:86-90, 1990.

20. Boston JR, Davis PJ, Brandom BW, Roeber CM: Rate of change of somatosensory evoked potentials in newborn piglets. Anesth Analg 70:275-283, 1990.

21. Brandom BW, Sarner JB, Woelfel SK, Dong ML, Horn MC, Borland LM, Cook DR, Foster VJ, McNulty BF, Weakly JN: Mivacurium chloride (BW B1090U) infusion requirements in pediatric surgical patients during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia. Anesth Analg 71:16-22, 1990.

22. Sarner JB, Brandom BW, Dong ML, Pickle D, Cook DR, Weinberger MJ: Clinical pharmacology of pipecuronium in infants and children during halothane anesthesia. Anesth Analg 71:362-366, 1990.

23. Woelfel SK, Dong ML, Brandom BW, Sarner JB, Cook DR: Vecuronium infusion requirements in children during halothane-narcotic-nitrous oxide, isoflurane-narcotic-nitrous oxide, and narcotic-nitrous oxide anesthesia. Anesth Analg 73:33-38, 1991.

24. Kosko JR, Brandom BW, Chan KH: Masseter spasm and malignant hyperthermia: A retrospective review of a hospital-based pediatric otolaryngology practice.
Int J Pediatr Otorhinolaryngol 23:45-50, 1992.

25. Blinn A, Woelfel SK, Cook DR, Brandom BW, Cohen IT: Pancuronium dose-response revisited. Paediatric Anaesthesia 2:153-155, 1992.

26. Powers DM, Brandom BW, Cook DR, Byers R, Sarner JB, Simpson K, Weber S, Woelfel SK, Foster VJ: Mivacurium infusion during nitrous oxide-isoflurane anesthesia: a comparison with nitrous oxide-opioid anesthesia. Journal of Clinical Anesthesia 4:123-126, 1992.

27. D'Angelo R, Cohen IT, Brandom BW: Continuous epidural infusion of bupivacaine and fentanyl for erythromelalgia in an adolescent. (Case Report) Anesth Analg 74:142-144, 1992.

28. Woelfel SK, Brandom BW, Cook DR, Sarner JB: Effects of bolus administration of ORG-9426 in children during nitrous oxide-halothane anesthesia. Anesthesiology 76:939-942, 1992.

29. Brandom BW, Meretoja OA, Taivainen T, Wirtavuori K: Accelerated onset and delayed recovery of neuromuscular block induced by mivacurium preceded by pancuronium in children. Anesth Analg 76:998-1003, 1993.

30. Meretoja OA, Brandom BW, Taivainen T, Jalkanen L: Synergism between atracurium and vecuronium in children. Br J Anaesth 71:440-442, 1993.

31. Woelfel SK, Brandom BW, McGowan FX, Cook DR: Clinical pharmacology of mivacurium in pediatric patients less than two years old during nitrous oxide-halothane anesthesia. Anesth Analg 77:713-720, 1993.

32. Woelfel SK, Brandom BW, McGowan Jr. FX, Gronert BJ, Cook DR: Neuromuscular effects of a bolus of 600 µg.kg-1 of rocuronium in infants during nitrous oxide-halothane anaesthesia. Paediatric Anaesthesia 4:173-177, 1994.

33. Meretoja OA, Taivainen T, Brandom BW, Wirtavuori K: Frequency of train-of-four stimulation influences neuromuscular response. Br J Anaesth 72:686-687, 1994.

34. Jalkanen L, Meretoja OA, Taivainen T, Brandom BW, Dayal B: Synergism between atracurium and mivacurium compared with that between vecuronium and mivacurium. Anesth Analg 79:998-1002, 1994.

35. Theroux MC , Brandom BW, Zagnoev M, Kettrick RG, Miller F, Ponce C: Dose response of succinylcholine at the adductor pollicis of children with cerebral palsy during propofol and nitrous oxide anesthesia. Anesth Analg 79:761-765, 1994.

36. Brandom BW, Taiwo OO, Woelfel SK, Schon H, Gronert BJ, Cook DR: Spontaneous Versus Edrophonium-Induced Recovery from Paralysis with Mivacurium. Anesth Analg 82: 999-1002, 1996.

37. Brandom BW, Yellon RF, Lloyd ME, Gronert BJ, Theroux M, Simhi E, Chakravorti S , Venkataraman S, Dohar JE, Shapiro AM, Rimmel FL, Reilly J. Recovery from Doxacurium Infusion Administered to Produce Immobility for More Than Four Days in Pediatric Patients in the Intensive Care Unit. Anesthesia Analgesia, in press, 1997.

38. Simhi E, Brandom BW, Lloyd ME, Woelfel SK: Administration of atropine and onset of neuromuscular block produced by atracurium in infants. Pediatric Anaesthesia, in press, 1997.

Reviews, Invited Published Papers, Proceedings of Conference and Symposia, Monographs, Books and Book Chapters.

Reviews:

1. Brandom BW, Cook DR: The clinical use of muscle relaxants in infants and children. In: Current Reviews in Clinical Anesthesia, Volume 4, Miami, Florida, 1984.

2. Brandom BW, Cook DR: Muscle relaxants in children. In: Seminars in Anesthesia, Vol IV, edited by Katz R, Grunne and Stratton, Inc., New York, 4:41-51, 1985.

3. Brandom BW: Neuromuscular blocking drugs in infants and children. Current Opinion in Anesthesiology, 1:24-30, 1988.

4. Brandom BW: New developments in pediatric anesthesia: Neuromuscular blocking drugs. Anesthesiology Clinics of North America, edited by Lerman J, C.V. Mosby Co., St. Louis, MO, 9:781-800, December 1991.

5. Law SC, Brandom BW: Monitoring neuromuscular function in the pediatric patient. In: International Anesthesiology Clinics, Anesthesia Equipment for Infants and Children, edited by Pullerits J and Holzman R, Little Brown and Co., Boston, MA, 30(3):147-162, 1992.

6. Brandom BW, Davis PJ: Changes in drug requirements during growth. Current Opinion in Anaesthesiology 5:374-379, 1992.

7. Brandom BW: New neuromuscular blocking drugs in anesthetized pediatric patients. Current Reviews in Clinical Anesthesia 12 (Lesson 26):8/13/92.

8. Woelfel SK, Brandom BW: Neuromuscular blocking drugs in pediatric anesthesia. Seminars in Anesthesia 11(4):286-291, 1992.

9. Brandom BW: Neuromuscular blocking drugs in pediatric anesthesia. Seminars in Anesthesia 14(1):16-25, 1995.


Invited Published Papers:

1. Brandom BW: The effects of atracurium and succinylcholine on the masseter. (Editorial) Can J Anaesth 37:7-11, 1990.

Letters:

1. Brandom BW, Cook DR. Dose response relationship to mivacurium in humans. Anesthesiology 70:1036-7, 1989.

2. Brandom BW, Meretoja OA. Dose response calculations revisited. (Comment on: Anesth Analg 1993;77:164-7.) Anesth Analg 78:608-9, 1994.

3. Brandom BW, Westman HR: The effects of 0.86 mg/kg of cisatracurium in an infant. Anesthesiology 85:688-9, 1996.


Proceedings:

1. Brandom BW, Brandom RB: A microcomputer based model of anesthetic uptake and distribution. Modeling and Simulation 11:295-300, 1980. Proceedings of the Eleventh Annual Pittsburgh Conference.

2. Tung AS, Brandom BW: 4-aminopyridine reversal of morphine analgesia in aminopyridines and similarly acting drugs: Effects on nerves, muscles, and synapses. Proceedings of the IUPHAR Satellite Symposium, 8th International Congress of Pharmacology, Pans, France, July 27-29, 1981. Advances in the Biosciences 35:233, editors Lechat P, Thesleff S, Bowman WC. Pergamon Press, 1982.

3. Brandom BW, Cook, DR, Stiller RL: Pharmacokinetics of atracurium in infants and children. Readings in Anesthesiology: Neuromuscular Blocking Agents. Presented as a syllabus for a symposium sponsored by Burroughs Wellcome Co. and the University of Pittsburgh School of Medicine, Department of Anesthesiology, 1985.

Book Chapters:

1. Brandom BW, Cook DR: Muscle relaxants in children. In: Muscle Relaxants, ed. Katz R, Grune & Stratton, Inc., New York, NY, Chapter 14, pp. 215-232, 1985.

2. Brandom BW, Carroll JC, Rosenberg H: Malignant hyperthermia. In: Smith's Anesthesia for Infants and Children, Fifth Edition, eds. Motoyama EK and Davis PJ, C.V. Mosby Co., St. Louis, MO, Chapter 29, pp. 759-777, 1989.

3. Brandom BW: Is there a place for infusion of muscle relaxants in clinical anesthesia? In: Problems in Anesthesia: Neuromuscular Relaxants, ed. Rupp SM, J.B. Lippincott Co., Philadelphia, PA, Vol. 3, No. 3, pp. 421-435, 1989.

4 Cook DR, Brandom BW: Pain control with general and local anesthetics. In: Human Pharmacology, Molecular to Clinical, eds. Wingard LB and Brody TM,
C.V. Mosby Co., St. Louis, MO, Chapter 30, 1991.

5. Brandom BW: Malignant hyperthermia and neurolept syndromes. In: Pediatric Critical Care, eds. Fuhrman BP and Zimmerman JJ, C.V. Mosby Co., St. Louis, MO, December, 1991.

6. Brandom BW: Masseter spasm. In: Common Problems in Pediatric Anesthesia, 2nd Edition, ed. Stehling L, C.V. Mosby Co., St. Louis, MO, Chapter 49, pp. 337-342, 1992.

7. Woelfel SK, Brandom BW: Anesthesia for the pediatric ophthalmology patient. In: Duane's Clinical Ophthalmology, eds. Tasman W and Jaeger EA,
J.B. Lippincott, Philadelphia, PA, 6(81):1-17, 1993.

8. Gronert BJ, Brandom BW: Neuromuscular blocking drugs in infants and children. In: Pediatr Clin North Am, ed. Wetzel RC, W.B. Saunders, Philadelphia, 41(1):73-91, 1994.

9. Brandom BW, Gronert GA: Malignant hyperthermia. In: Smith's Anesthesia for Infants and Children Sixth Edition, eds. Motoyama EK and Davis PJ, Mosby-Year Book, St. Louis, Chapter 27, pp. 809-826, 1996.

Published Abstracts.

1. Motoyama EK, Brandom BW, Mestad PM, Walczak SA: Esophageal pressure monitoring in infants. Anesthesiology Vol 53, No. 3, September 1980.

2. Brandom BW, Lin M, Tung AS: 4-aminopyridine reversal of ketamine anesthesia. The Pharmacologist Vol. 23, No. 3, 1981.

3. Tung AS, Brandom BW, Figallo EM: 4-aminopyridine reversal of ketamine anesthesia and morphine analgesia. Anesthesiology 55:A240, September 1981.

4. Tung AS, Brandom BW: 4-aminopyridine reversal of morphine analgesia. Abstracts of the Society for Neuroscience 11th Annual Meeting, p. 798. October 1981.

5. Cook DR, Brandom BW, Rudd D: Clinical pharmacology of atracurium (BW33A) in pediatric patients. Anesthesiology 57:A415, 1982.

6. Brandom BW, Woelfel SK, Cook DR, Fehr B, Rudd D: Relative potency of atracurium in children during halothane, isoflurane or thiopental-fentanyl anesthesia. Anesthesiology 59:A442, 1983.

7. Brandom BW, Woelfel SK, Cook DR, Fehr B, Rudd D: Clinical pharmacology of atracurium in infants. Anesthesiology 59:A440, 1983.

8. Cook DR, Brandom BW, Woelfel SK, Fehr B, Rudd D: Atracurium infusion in children during fentanyl, halothane and isoflurane anesthesia. Anesth Analg 63:201, 1984.

9. Cook DR, Brandom BW, Stiller RL, Woelfel S, Lai A, Slater J: Pharmacokinetics of atracurium in normal and liver failure patients. Anesthesiology 61:A433, 1984.

10. Brandom BW, Weber S, Cook DR, Powers D, Woelfel SK, Marquez J, Weakly JN: Comparison of the effects of BW B1090U and succinylcholine administered by bolus and infusion in anesthetized patients. Anesthesiology 65:A288, 1986.

11. Cook DR, Stiller RL, Chakravorti S, Welch RM, Brandom BW: In vitro metabolism of BW B1090U. Anesthesiology 67:A610, 1987.

12. Sarner JB, Brandom BW, Woelfel SK, Horn M, Cook DR, Dong ML, Davis PJ, Foster VJ, McNulty BF: Neuromuscular effects of BW A938U in anesthetized children. Anesthesiology 67:A365, 1987.

13. Powers D, Weber S, Brandom BW, Byers R, Simpson K, Sarner J, Woelfel SK, Cook DR, McNulty BF, Foster VJ: BW B1090U infusion requirements in adults during isoflurane or narcotic anesthesia. Anesthesiology 67:A359, 1987.

14. Weber S, Brandom BW, Powers D, Sarner JB, Woelfel SK, Cook DR, Foster VJ, Weakly JN: Relative potency of BW B1909U during isoflurane or thiopental-fentanyl anesthesia. Anesthesiology 67:A356, 1987.

15. Tullock WC, Diana P, Cook DR, Wilks DH, Brandom BW, Beach CA: High dose vecuronium: Onset and duration. Anesth Analg 67:S235, 1988.

16. Woelfel SK, Brandom BW, Sarner JB, Horn M, Dong ML, Cook DR, Davis PJ, Foster VJ, McNulty BF: Potency of mivacurium chloride (BW B1090U) during halothane-nitrous oxide anesthesia in children. Anesth Analg 67:S261, 1988.

17. Brandom BW, Sarner JB, Dong ML, Horn M, Woelfel SK, Cook DR, Borland LM, Davis PJ, Foster VJ, McNulty BF: Mivacurium chloride (BW B1090U) infusion requirements in children during halothane or narcotic anesthesia. Anesth Analg 67:S20, 1988.

18. Sarner JB, Brandom BW, Woelfel SK, Dong ML, Horn M, Cook DR, Foster VJ, McNulty BF: Potency of mivacurium chloride (BW B1090U) during narcotic-nitrous oxide anesthesia in children. Anesthesiology 69:A522, 1988.

19. Woelfel SK, Brandom BW, Cook DR, Whitehead B, Borland L: Relationship between the time to beginning of recovery after the initial bolus of muscle relaxant and the infusion rate requirements for mivacurium and succinylcholine. Anesthesiology 69:A521, 1988.

20. Brandom BW, Sarner JB, Dong ML, Woelfel SK, Horn M, Cook DR, Foster VJ, McNulty BF: Plasma concentrations of mivacurium chloride during infusion administration in children anesthetized with halothane-nitrous oxide or narcotic-nitrous oxide. Anesth Analg 68:S38, 1989.

21. Kusakawa I, Brandom BW, Motoyama E, Deneault LG, Ochiai R, Lutz JW: Comparison of spontaneous inspiratory muscle activities and train-of-four tibialis anterior response with low dose atracurium in the cat. Anesthesiology 71:A1110, 1989.

22. Dong ML, Woelfel SK, Brandom BW, Sarner JB, Cook DR: Vecuronium infusion requirements in children during halothane-N2O, isoflurane-N2O, and fentanyl-N2O anesthesia. Anesthesiology 71:A1039, 1989.

23. Boston JR, Davis P, Brandom BW, Roeber C: Similarity in time-related changes of somatosensory evoked potentials and isoflurane. Anesthesiology 71:A398, 1989.

24. Sarner JB, Brandom BW, Dong ML, Pickle D, Weinberger M, Cook DR: The cumulative dose-response relationship of pipecuronium bromide (Arduan) in infants and children. Anesthesiology 71:A778, 1989.

25. Theroux MC, Brandom BW, Cook DR: Neuromuscular monitoring of the flexor hallucis brevis compared with the adductor pollicis in anesthetized children. Anesth Analg 70:S408, 1990.

26. Brandom BW, Georgiu E, Cook DR: Effects of vecuronium on the flexor hallucis brevis compared with the adductor pollicis in anesthetized children. Anesthesiology 73:A1112, 1990.

27. Brandom BW, Stiller RL, Cook DR, Scierka AM: Differential rate of recovery of neuromuscular function in the adductor pollicis and the flexor hallucis after vecuronium. Anesthesiology 73:A1113, 1990.

28. Tullock WC, Wilks DH, Brandom BW, Diana P, Cook DR: ORG9426 single dose-response, onset, and duration with halothane anesthesia. Anesthesiology 73:A877, 1990.

29. Woelfel SK, Brandom BW, Sarner JB, Cook DR, Cyran JA: Dose-response of ORG-9426 in children during nitrous oxide-halothane anesthesia. Anesth Analg 72:S326, 1991.

30. Brandom BW, Woelfel SK, Sarner JB, Cook DR: ORG 9426 infusion requirements in children during halothane anesthesia. Anesthesiology 75:A1072, 1991.

31. Tullock WC, Wilks DH, Brandom BW, Cook DR: ORG 9426: onset, intubation conditions and clinical duration. Anesthesiology 75:A789, 1991.

32. Woelfel SK, Brandom BW, McGowan FX, Cook DR: Dose-response relationships of mivacurium chloride (Mivacron) in infants during nitrous oxide-halothane anesthesia. Anesthesiology 75:A775, 1991.

33. Woelfel SK, Brandom BW, McGowan FX, Cook DR: Stability of Datex neuromuscular monitoring in anesthetized infants. Anesth Analg 74:S352, 1992.

34. Powers D, Lefebvre D, Knos G, Cyran J, Brandom BW: Intubation Conditions After Administration of ORG 9426 During Nitrous Oxide-Fentanyl-Midazolam Anesthesia. Anesth Analg 74:S240, 1992.

35. Cook DR, Chakravorti S, Brandom BW, Stiller RL: Effects of Neostigmine, Edrophonium and Succinylcholine on the in vitro Metabolism of Mivacurium: Clinical Correlates. Anesthesiology 77:A948, 1992.

36. Woelfel SK, Brandom BW, McGowan FX, Cook DR: Plasma Cholinesterase Activity and Response to Mivacurium in Infants. Anesthesiology 77:A966, 1992.

37. Powers D, Lefebvre D, Knos G, Cyran J, Brandom B: Intubation Conditions After Administration of ORG-9426 During Nitrous Oxide-Fentanyl-Midazolam Anesthesia. Anesth Analg 74:S240, 1992.

38. Brandom BW, Meretoja OA, Taivainen T, Wirtavuori K: A Small Dose of Pancuronium Preceding Paralysis Induced by Mivacurium. Anesth Analg 76:S27, 1993.

39. Meretoja OA, Brandom BW, Wirtavuori K, Taivainen T: Neuromuscular Effects of a Combination of Atracurium and Vecuronium in Equipotent Ratio. Anesth Analg 76:S260, 1993.

40. Woelfel SK, Gronert BJ, Brandom BW, McGowan FX, Cook DR: Effects of ORG-9426 in Infants During Halothane Anesthesia. Anesth Analg 76:S467, 1993.

41 Brandom BW, Cook DR, Chakravorti S, Stiller RL: Effects of Pancuronium and Vecuronium on the in vitro Metabolism of Mivacurium, Succinylcholine and Propionylthiocholine. Anesthesiology 79:A949, 1993.

42. Theroux M, Brandom B, Zagnoev M, Kettrick R: Dose Response of Succinylcholine in Anesthetized Children with Cerebral Palsy. Anesthesiology 79:A1125, 1993.

43. Theroux MC, Zagnoev M, Brandom BW, Drago LA: Comparison of Rapid Endotracheal Intubations Using Succinylcholine, Mivacurium and Vecuronium to Combinations of Mivacurium and Vecuronium. Anesth Analg 78:S436, 1994.

44. Simhi E, Brandom BW, Gronert BJ, Woelfel SK: Timing of Intubation in Children After 300 mg/kg Mivacurium. Anesthesiology 83:A902, 1995.

45. Taiwo OO, Woelfel SK, Brandom BW, Schoen HE, Gronert BJ, Cook DR: Spontaneous vs Edrophonium Induced Recovery From Paralysis with Mivacurium. Anesthesiology 83:A900, 1995.

46. Brandom BW, Woelfel SK, Gronert BJ, Cook DR, Ference A, Dayal B: Effects of 51W89 (Cistracurium) in Children during Halothane Nitrous Oxide Anesthesia. Anesthesiology 83:A921, 1995.

47. Brandom BW, Gronert BJ, Woelfel SK, Cook DR: Lack of Synergy Between Mivacurium and Doxacurium or Pipecuronium. Anesth Analg 82:S46, 1996.

48. Brandom BW, Gronert BJ, Yellon RF, Lloyd ME, Shapiro AM, Rimmel FL: Doxacurium Infusion Given For More Than Five Days In The Intensive Care Unit. Anesth Analg 82:S47, 1996.

49. Brandom BW, Meretoja OA, Gronert BJ, Woelfel SK, Cook DR: Synergy Between Mivacurium and Pancuronium. Anesth Analg 82:S48, 1996.

50. Simhi E, Brandom BW, Gronert BJ, Woelfel SK: Intubation Scale For Children. Anesth Analg 82:S412, 1996.

51. Tarbell SE, Brandom BW, Davis PJ, Kosmach B: Chronic Pain in Childhood: Add Munchausen by Proxy to the Differential Diagnosis. 8th World congress on Pain, 1996.

52. Simhi E, Cook DR, Brandom BW, Lloyd ME, Chakravorti S, Kuntz R. Pharmacokinetics of Mivacurium in anesthetized Pediatric Patients undergoing Elective Surgery. Anesthesiology 85:A1061, 1996.

53. Brandom BW, Meretoja OA, Simhi E, Taivainen T, Wolfe S, Woelfel SK, Gronert BJ, Cook DR: Effects of Mivacurium 0.3 mg/kg in pediatric surgical patients during nitrous oxide-halothane compared with nitrous oxide-opioid anesthesia. Anesth Analg 84:S???1997.

54. Brandom BW, Lloyd ME, Woelfel SK, Simhi E, Landsman IS. Comparison of the Datex Electromyograph and Paragraph Monitors During Recovery from Pancuronium in Anesthestized Children. Anesth Analg 84:S???1997.

55. Simhi E, Brandom BW, Lloyd ME, Woelfel SK: Administration of atropine and onset of neuromuscular block produced by atracurium in infants. Anesth Analg 84:S???1997.